#5M5Q
RBQM Interviews

Gain insights from top industry experts, sponsors, and CROs as they share tips and visions for the future RBQM. Explore the latest strategies and innovative practices to elevate your quality management processes.


    SPONSOR
    Miguel Valenzuela

    Miguel Valenzuela

    • AD, Clinical Risk and Analytics
    • Alnylam Pharmaceuticals
    SPONSOR

    Brian Barnes

    • Director, Risk Management Strategy
    • BIONTECH
    CRO

    Jennifer Stewart

    • Executive Director, Clinical Data Sciences
    • Premier Research
    CRO

    Shawntel Swannack

    • Head, Risk-Based Quality Management
    • Emmes
    CRO

    Molly Peterson

    • Clinical Risk Manager
    • Worldwide Clinical Trials
    Complimentary Training

    Expert-Led GCP Training

    • Learn at your own pace
    • Featuring RBQM & GCP experts
    TESTIMONIALS

    RBQM Success Stories

    Hear directly from our partners about how we've helped them.

    Kelly Parish Holladay AD, RBQM, Worldwide

    It has been such a wonderful ride with our TRI partners over the last few years developing our RBQM strategy with our Sponsors and Worldwide Clinical Trials Teams! We love working with everyone at TRI and look forward to bigger and better things to come!

    Peter Benton President & CEO, Worldwide

    Worldwide’s RBQM team is one of the most experienced CRO teams in the industry. This, coupled with TRI’s best-in-class technology, ensures we can proactively identify and manage risks, meaning improved quality and patient safety, and, in turn, provide a better experience for sponsors and patients.

    Jeff Smith Former CEO, Alimentiv

    What truly set TriTrials apart from other vendors was their unparalleled commitment to a quality deliverable helping us effectively apply a novel approach to our operations. They achieved a deep understanding of our objectives by partnering with us on a rigorous change management process which culminated in a shared vision for the integration of their risk assessment and central monitoring solution.

    Amandeep Sonik Senior Director, RBQM, Worldwide

    The Worldwide Clinical Trials team is pleased with our continued partnership with TRI and we are excited about the milestone of having 150 clinical trials in TRI's Risk-Based Quality Management platform. This is a key benefit for our customers as it improves data quality, trial efficiency, and patient safety.

    Kelly Parish Holladay AD, RBQM, Worldwide

    It has been such a wonderful ride with our TRI partners over the last few years developing our RBQM strategy with our Sponsors and Worldwide Clinical Trials Teams! We love working with everyone at TRI and look forward to bigger and better things to come!

    Peter Benton President & CEO, Worldwide

    Worldwide’s RBQM team is one of the most experienced CRO teams in the industry. This, coupled with TRI’s best-in-class technology, ensures we can proactively identify and manage risks, meaning improved quality and patient safety, and, in turn, provide a better experience for sponsors and patients.

    RBQM NEWS

    Clinical trial quality news and views

    Subscribe to get the latest RBQM insights sent to your mailbox.

    What is ICH E6 (R3)?

    What is ICH E6 (R3)?

    ICH E6 (R3) sets a new global benchmark for Good Clinical Practice, modernizing oversight with principle-based, risk-driven, and digitally enabled trial design.

    The Quality Issue – July 2025

    The Quality Issue – July 2025

    ICH E6(R3) is now effective in the EU, marking a pivotal shift in clinical trial oversight. This issue breaks down what it means and how to stay ahead.

    TRI launches major overhaul of OPRA-CM

    TRI launches major overhaul of OPRA-CM

    TRI’s reimagined OPRA-CM platform delivers on the true promise of RBQM, cutting through complexity to enable smarter, faster, and more focused centralized monitoring.